Insight Strategy Advisors (ISA) is a healthcare consulting firm headquartered in New York City. ISA provides commercial development strategy expertise to multinational biopharmaceutical companies — serving clients in New York, Philadelphia, Chicago, Boston, Raleigh, San Francisco, Los Angeles, London, Paris, Tokyo and Switzerland.

ISA delivers value to clients through a diverse staff with expertise built from prior industry experience and direct industry knowledge gained from defining, creating, and executing commercial development strategies that maximize the economic value of therapeutic area franchises and products.


News Crawler

While FDA’s oversight and expectations for device makers using social media is still hazy, two experts advise companies to put more >>
Fri, Oct 31, 2014 4:00:00 AM, Continue reading at the source
McNeil scaled up its manufacturing “volume and complexity substantially” following J&J’s acquisition of Pfizer’s consumer business in 2006, says McNeil more >>
Fri, Oct 31, 2014 4:00:00 AM, Continue reading at the source
Cardio-renal committee votes 9-1 for approval of Daiichi’s anticoagulant for stroke risk reduction in patients with nonvalvular atrial fibrillation, but more >>
Fri, Oct 31, 2014 2:25:00 AM, Continue reading at the source